Navigation Links
BioDrain Medical Inc. Appoints New Board Member
Date:3/14/2012

MINNEAPOLIS, March 14, 2012 /PRNewswire/ -- BioDrain Medical, Inc. (OTCBB: BIOR, OTCQB: BIOR), producer of the FDA cleared STREAMWAY System for automated surgical fluid disposal, announced today that it has appointed Joshua Kornberg to the Company's Board of Directors.

Kevin Davidson, Chief Executive Officer of BioDrain, commented, "We are thrilled to bring Josh onboard. As cofounder of Atlantic Partners Alliance, a healthcare and biotechnology fund dedicated to bridge financing of companies in search of short-term capital, Josh brings to our Board an excellent understanding of how to help an early stage company progress. We are confident that his consulting expertise in regards to sales, marketing, and strategic development, as well as in technical strategies such as regulatory adherence, clinical staging and product evaluation, will be extremely valuable in building out our operations and increasing awareness in the medical device community of the benefits of our unique STREAMWAY System."

Mr. Kornberg is also President and founding partner of GPF, a private equity fund based in New York. Prior to founding GPF, Mr. Kornberg served as Chief Investment Officer of The Lightstone Group, a national private equity firm, and Director of the Lightstone Value Plus REIT, a public company focused on commercial real estate. Additionally, Mr. Kornberg served as Director of Acquisitions and Development at ARK Realty Investors, a real estate investment and development firm. He also worked in the capital markets group at Morgan Stanley and served as Vice President at The RREEF Funds, a leading global pension fund advisor.

About BioDrain Medical, Inc.

BioDrain Medical, Inc. has a fully automated, patented and FDA cleared surgical fluid disposal system that virtually eliminates operating room workers' exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment. Current manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and an antiquated approach to the handling of surgical fluid waste. BioDrain's STREAMWAY System however fully automates the collection, measurement and disposal of surgical fluids, resulting in: 1) reducing overhead costs to hospitals and surgical centers, 2) improving the Occupational State and Health Association (OSHA) and other regulatory compliance, and 3) improving the efficiency of the operating room (and thereby making surgeries more profitable).

BioDrain's STREAMWAY System presents a sustainable solution to fluid disposal in operating rooms. Presently, around 50 million bloody, potentially disease infected canisters go to landfills in the United States annually. Moreover, these tainted canisters can remain in landfills for years. With the installation of BioDrain's STREAMWAY System, the number of these canisters can be significantly reduced, making both the operating room and our environment safer and cleaner. Independent professional sales representatives that cater to the needs of hospitals and ambulatory surgical centers across the country are currently representing BioDrain products. For additional information, please visit: www.biodrainmedical.com.

Forward-looking Statements:

Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the company's ability to implement its long range business plan for various applications of its technology; the company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the company's reports filed with the Securities and Exchange Commission. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the company's financial position. See the company's most recent Quarterly Report on Form 10-Q and related 8-K filings.

Investor Relations Contact:

Mr. Kevin Fickle, President
NUWA Group LLC
Tel: +1-925-330-8315
Email: kevin@nuwagroup.com

Or

Stanley Wunderlich
Consulting for Strategic Growth 1 Ltd.
Tel: 800-625-2236 ext. 7770
Email: info@cfsg1.com

 


'/>"/>
SOURCE BioDrain Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BioDrain Streamway® System Receives Positive Evaluations on Two Additional Units
2. BioDrain Medical, Inc. Reports Results of Annual Meeting
3. BioDrain Medical, Inc. Retains EKN Financial Services as Its Exclusive Financial Advisor and Placement Agent
4. BioDrain Medical, Inc. Completes Installation of Its Streamway™ Automated Surgical Fluid Disposal System in Minnesota Hospital
5. BioDrain Medical, Inc. Retains CFSG1 as Its U.S. Investor Relations Firm
6. BioDrain Medical, Inc. Is Eligible for Trading on the OTCBB, Notice of Allowance on Canadian Patent Application
7. American Capital and its Affiliates Invest $20 Million in Portfolio Company Halt Medical
8. Solta Medical Provides Update on Liposonix Launch
9. Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets
10. UMF Medical Announces New Name
11. Benchmark Mobility Inc. Annouces Sell of Home Medical Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 23, 2017  Provectus Biopharmaceuticals, Inc. ... "Company"), a clinical-stage oncology and dermatology biopharmaceutical company, ... Financing Commitment Term Sheet (the "Definitive Financing") it ... of the Company,s stockholders, who are referred to ... a Form 8-K filed with the Securities and ...
(Date:3/23/2017)... The key factors driving the growth ... accelerating economic growth and increasing healthcare expenditure. Some of the ... expectancy of ESRD patients, rising demand for home PD treatment ... of the market is hindered by high treatment costs and ... ...
(Date:3/23/2017)... -- As a result of diagnostic technology increasing ... allergic diseases, cutting edge developments in targeted drugs ... in which pharmaceutical and biotech companies are addressing ... both a high quality meeting and a platform ... research scholars and doctors. The event will also ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... 24, 2017 , ... “End Time GPS”: a dauntless and enlightened study ... Time GPS” is the creation of published author, Wesley Gerboth, a World War II ... and space-vehicle projects. Now, at age ninety-one, he shares the Wisdom God bestowed upon ...
(Date:3/24/2017)... ... , ... “The Adventures of Joey, The Dog Who Barks at Puddles”: a ... to the fullest, as God intended. “The Adventures of Joey, The Dog Who Barks ... pursuing her passion for writing, especially about truth and human behavior. , Published by ...
(Date:3/23/2017)... ... ... The physicians of KSF Orthopaedic Center PA are proud to announce the ... located at 2255 E. Mossy Oaks Rd., Suite 440, Spring, Texas 77389 inside the ... living in the north Houston area (The Woodlands, Conroe, Magnolia, Kingwood, Humble) with an ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... Oklahoma City Convention Center at 10 North Broadway Avenue, will be an educational ... of relevant, practical instruction in the management of chronic pain. , Oklahoma is ...
(Date:3/23/2017)... ... ... of adults are unaware of the dangers that infectious bacteria play in mouth disease, while ... a day that dentists recommend. The ramifications of improper oral upkeep go far beyond bad ... 164 million hours of work each year due to dental issues. That is why Mediaplanet ...
Breaking Medicine News(10 mins):